Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maksim Mamonkin

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Cell Reports|October 6, 2017
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentDiogo Gomes-Silva, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Cancer Immunology Research|January 19, 2020
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaSai Arun Batra, Purva Rathi, Linjie Guo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Blood|January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemiaWingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Blood|August 31, 2022
Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantationFeiyan Mo, Norihiro Watanabe, Kayleigh I Omdahl, et al.
Stem Cells Translational Medicine|May 31, 2025
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapyWei-Hsin Liu, Anat Globerson Levin, Assaf Lask, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Nature Biotechnology|July 15, 2020
Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.
Cell Reports. Medicine|July 10, 2024
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicityRoyce Ma, Mae Woods, Phillip Burkhardt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cell Reports|October 6, 2017
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentDiogo Gomes-Silva, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Cancer Immunology Research|January 19, 2020
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular CarcinomaSai Arun Batra, Purva Rathi, Linjie Guo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Blood|January 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemiaWingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, et al.
Blood|August 31, 2022
Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantationFeiyan Mo, Norihiro Watanabe, Kayleigh I Omdahl, et al.
Stem Cells Translational Medicine|May 31, 2025
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapyWei-Hsin Liu, Anat Globerson Levin, Assaf Lask, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Nature Biotechnology|July 15, 2020
Engineered off-the-shelf therapeutic T cells resist host immune rejectionFeiyan Mo, Norihiro Watanabe, Mary K McKenna, et al.
Cell Reports. Medicine|July 10, 2024
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicityRoyce Ma, Mae Woods, Phillip Burkhardt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 10, 2022
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignanciesNorihiro Watanabe, Feiyan Mo, Rong Zheng, et al.
Pageof 6